IV Medications Elsevier

#1 IV Drug Handbook - 50 years

Published by: Skyscape Medpresso
Downloads
Revenue

Description

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
Use the #1 IV drug handbook to safely administer more than 400 intravenous drugs! Includes the most recent IV drugs to be approved by the FDA
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2024 edition are 8 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
KEY FEATURES
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference.
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
- Additional drug monographs are provided on the Evolve website.
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks.
- Blue-screened text calls attention to special circumstances not covered by Black Box Warnings.
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information.
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
Content licensed from printed edition ISBN-10: 0443121109
Content licensed from printed edition ISBN-13: 9780443121104
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $49.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: [email protected] or call 508-299-3000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Author(s):Shelly Rainforth Collins, PharmD
Publisher:Elsevier Health Sciences
Hide Show More...

In-Apps

Intravenous Medications 2022
59,99 USD
Elsevier IV Med HBK 1Y Sub off
47,99 USD
Elsevier’s IV Med HBK 1Y Sub
49,99 USD
Elsevier’s IV Med HBK 6M Sub
32,99 USD
Elsevier’s IV Med HBK 3/M Sub
25,99 USD

Screenshots

IV Medications Elsevier FAQ

  • Is IV Medications Elsevier free?

    Yes, IV Medications Elsevier is free to download, however it contains in-app purchases or subscription offerings.

  • Is IV Medications Elsevier legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does IV Medications Elsevier cost?

    IV Medications Elsevier has several in-app purchases/subscriptions, the average in-app price is USD 43.39.

  • What is IV Medications Elsevier revenue?

    To get estimated revenue of IV Medications Elsevier app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Ukraine yet.
Ratings History

IV Medications Elsevier Reviews

Incorrect brand-generic conversions

Phrexy on

United States

Searching and tapping unasyn opens amifostine instead of unasyn. Thankfully this was caught. Edit: search “keppra” and the incorrect generic “lacosamide” comes up. This app is untrustworthy and can longer be used as reference.

Drugs are current and updated

Rustybag on

United States

The drug database updates with the actual publishers content. Peace of mind when dealing with newly approved FDA medications.

Unreasonable full access price.

Andichdjay on

United States

This app would be great if it wasn’t overpriced. $49.99 seems unreasonably high.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Keywords

IV Medications Elsevier Competitors

Name
Nurse's Pocket Guide-Diagnosis
Nursing Diagnosis, Care Plans
Pocket ICU
Best-Selling Critical Care App
Mosby's Drug Reference
Over 5,000 Drug Listings
PEPID®
Critical- Medical Guide
IV Medications Gahart
#1 IV Reference for Nurses
Nurse's Drug Handbook
Rx pharmacology reference
RNotes®
Nurse's Clinical Pocket Guide
Pocket Infusion Calculator
IV Pump and Drip Rate
Diseases & Disorders
Coverage of 240+ Diseases

IV Medications Elsevier Installs

Last 30 days

IV Medications Elsevier Revenue

Last 30 days

IV Medications Elsevier Revenue and Downloads

Gain valuable insights into IV Medications Elsevier performance with our analytics.
Sign up now to access downloads, revenue, and more.